Researchers looked at cancer therapy trastuzumab (Herceptin) and found biosimilars bring competition to the market, with prices declining by more than half for some versions.
The first study to examine biosimilar drivers finds commercial insurers limit use in almost 20% of cases.
Darius Lakdawalla was part of a panel of experts called upon by the U.S. House Ways and Means Subcommittee on Health.
USC Schaeffer white paper finds that increasing access to obesity treatments would help save lives and reduce healthcare costs.
The researchers propose three strategies for mitigating negative impacts of the Inflation Reduction Act to ensure greater patient access, increased innovation and lower costs.
Karen Van Nuys testified at the hearing, calling transparency “an essential first step.”
Priselac, who is CEO and president of Cedars-Sinai, has served on the board since its inception in 2011.
Medicare Advantage plans have seen a more than 300% increase in enrollment—with payment policy yet to catch up.
Most Americans don’t know the meaning of 120-80 mm Hg, but think they do.
Letters successfully encouraged clinicians to check patients’ prescribing records, says study co-author Mireille Jacobson.